Form 8-K - Current report:
SEC Accession No. 0001437749-24-035686
Filing Date
2024-11-19
Accepted
2024-11-19 08:00:31
Documents
16
Period of Report
2024-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K allr20241118_8k.htm   iXBRL 8-K 29323
2 EXHIBIT 99.1 ex_749318.htm EX-99.1 18987
7 atlogosmall.jpg GRAPHIC 5907
  Complete submission text file 0001437749-24-035686.txt   202812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA allr-20241118.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE allr-20241118_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allr-20241118_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allr-20241118_pre.xml EX-101.PRE 12458
18 EXTRACTED XBRL INSTANCE DOCUMENT allr20241118_8k_htm.xml XML 3037
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 241473396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)